Literature DB >> 9230233

Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival.

H S Park1, K S Jung, J Shute, K Roberts, S T Holgate, R Djukanović.   

Abstract

Eosinophilia is a feature of nasal polyposis. The aim of this study was to determine the role of cytokines and allergen in maintaining the eosinophilic infiltrate in this condition. Polyp fragments from house dust mite (HDM)-sensitive atopic individuals and nonatopic individuals were cultured in the presence of HDM, or phytohaemagglutinin (PHA) or culture medium alone. Culture supernatants were assayed for interleukins (IL) 3, 5, and 8 and granulocyte macrophage colony stimulating factor (GM-CSF), and eosinophil survival enhancing activity (ESEA) in vitro. Significant ESEA was produced spontaneously. When polyp tissue from atopics, but not from nonatopics, was stimulated with allergen for 2 days there was a further increase in ESEA associated with a median 12 and fourfold increase in IL-8 and GM-CSF, respectively. This increased ESEA was markedly reduced with anti-GM-CSF and, to a lesser extent, anti-IL-8 blocking antibodies. When stimulated with PHA, polyp tissue from atopic subjects also produced increased ESEA, implicating possible T-cell involvement. This was associated with a small (twofold), but significant, increase in IL-8 and a less consistent increase in GM-CSF. However, anti-IL-8 or anti-GM-CSF blocking antibodies failed to reduce the ESEA in these supernatants, suggesting involvement of other mechanisms. This study suggests that in sensitized individuals, allergen may contribute to polyp eosinophilia by stimulating the production of granulocyte/macrophage colony stimulating factor and interleukin 8.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230233     DOI: 10.1183/09031936.97.10071476

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  2 in total

1.  Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.

Authors:  Monica Baiula; Antonino Spartà; Andrea Bedini; Gioia Carbonari; Claudio Bucolo; Keith W Ward; Jin-Zhong Zhang; Paolo Govoni; Santi Spampinato
Journal:  Mol Vis       Date:  2011-12-14       Impact factor: 2.367

2.  Apoptosis in eosinophilic nasal polyps treated in vitro with mitomycin C.

Authors:  Cláudia Pena Galvão dos Anjos; Anilton Cesar Vasconcelos; Paulo Fernando Tormin Borges Crosara; Gustavo Coelho dos Anjos; Celso Gonçalves Becker; Roberto Eustáquio Santos Guimarães
Journal:  Braz J Otorhinolaryngol       Date:  2012-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.